Harrow, Inc. Debt Instrument, Interest Rate During Period
Harrow, Inc. (HROW) reported Debt Instrument, Interest Rate During Period of 10.29% for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-10.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentInterestRateDuringPeriod · last filed 2025-11-10
- Harrow, Inc. debt instrument, interest rate during period for the quarter ending 2025-09-30 was 10.29%, a 6.71% decline year-over-year.
- Harrow, Inc. debt instrument, interest rate during period for the quarter ending 2025-06-30 was 10.65%, a 1.21% decline year-over-year.
- Harrow, Inc. debt instrument, interest rate during period for the quarter ending 2025-03-31 was 10.73%, a 0.46% decline year-over-year.
- Harrow, Inc. debt instrument, interest rate during period for the quarter ending 2024-09-30 was 11.03%, a 2.32% increase year-over-year.
- Harrow, Inc. debt instrument, interest rate during period for fiscal 2024 was 10.74%, a 1.51% increase from fiscal 2023.
- Harrow, Inc. debt instrument, interest rate during period for fiscal 2023 was 10.58%, a 17.95% increase from fiscal 2022.
- Harrow, Inc. debt instrument, interest rate during period for fiscal 2022 was 8.97%.
| Period end | Debt Instrument, Interest Rate During Period 3 month | Debt Instrument, Interest Rate During Period 6 month | Debt Instrument, Interest Rate During Period 9 month | Debt Instrument, Interest Rate During Period 12 month | Debt Instrument, Interest Rate During Period 12 month as first filed |
|---|---|---|---|---|---|
| 2025-09-30 | 10.29% 10-Q · filed 2025-11-10 | 10.41% 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | 10.65% 10-Q · filed 2025-08-11 | 10.74% 10-Q · filed 2025-08-11 | |||
| 2025-03-31 | 10.73% 10-Q · filed 2025-05-08 | ||||
| 2024-12-31 | 10.74% 10-K · filed 2025-03-27 | ||||
| 2024-09-30 | 11.03% 10-Q · filed 2025-11-10 | 11.17% 10-Q · filed 2025-11-10 | |||
| 2024-06-30 | 10.78% 10-Q · filed 2025-08-11 | 10.88% 10-Q · filed 2025-08-11 | |||
| 2024-03-31 | 10.78% 10-Q · filed 2025-05-08 | ||||
| 2023-12-31 | 10.58% 10-K · filed 2025-03-27 | 10.93% 10-K · filed 2024-03-19 | |||
| 2023-09-30 | 10.78% 10-Q · filed 2024-11-14 | 10.91% 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | 10.71% 10-Q · filed 2024-08-07 | 10.81% 10-Q · filed 2024-08-07 | |||
| 2023-03-31 | 10.78% 10-Q · filed 2024-05-13 | ||||
| 2022-12-31 | 8.97% 10-K · filed 2024-03-19 | ||||
| 2022-09-30 | 8.88% 10-Q · filed 2023-11-13 | 8.96% 10-Q · filed 2023-11-13 | |||
| 2022-06-30 | 8.88% 10-Q · filed 2023-08-09 | 8.94% 10-Q · filed 2023-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |